Clinical trials: Acne Rosacea
Rosacea, Papulopustular
Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device
10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
- Trial name
- NCT05592548
- Testing
- cold atmospheric plasma
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- The Skin Center Dermatology Group
Rosacea
Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea
This study compares three approaches to treating persistent facial redness in adults with erythematotelangiectatic rosacea: intense pulsed light (IPL) treatment alone, a professional anti-redness dermocosmetic skincare regimen…
- Trial name
- NCT07729540
- Testing
- Intense Pulsed Light (IPL) - Lumecca, Rosacure anti-redness dermocosmetic regimen
- Where
- Poland
- Volunteers
- 60 people
- Sponsor
- Medical University of Silesia
Rosacea
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
- Trial name
- NCT00668655
- Testing
- Metronidazole Gel
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Galderma R&D
Rosacea, Bilaterally Symmetric Red Skin on Cheeks
Topical Agent for Treatment of Red Skin
SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety
- Trial name
- NCT00279890
- Testing
- Topical SR-01
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Mayo Clinic
Facial Rosacea
Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea
To evaluate the therapeutic equivalence and safety of ivermectin cream 1% (Zydus Worldwide DMCC) and Soolantra® (ivermectin) cream, 1% (Galderma Laboratories, L.P.) in the treatment of moderate to severe facial papulopustular…
- Trial name
- NCT04106726
- Testing
- Soolantra® Ivermectin cream 1%, Ivermectin cream 1%
- Where
- 11 sites in United States
- Volunteers
- 525 people
- Sponsor
- Zydus Worldwide DMCC
Atopic Dermatitis, Acne Rosacea
Inflammatory Cells From Various Pathologies
The objective of this experiment is to develop and validate in vitro methods to isolate inflammatory cells from skin biopsies for quantitative flow cytometry analysis.
- Conditions
- Atopic Dermatitis, Acne Rosacea, Acne Vulgaris
- Trial name
- NCT02270411
- Where
- Canada
- Volunteers
- 95 people, healthy volunteers welcome
- Sponsor
- Innovaderm Research Inc.
Rosacea
Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream
Single dose bioequivalence study of Ivermectin 1% cream and Soolantra (Ivermectin) 10 mg/g cream in healthy adult human subjects.
- Trial name
- NCT06557603
- Testing
- Ivermectin cream, Soolantra ® (Ivermectin) cream
- Where
- India
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Humanis Saglık Anonim Sirketi
Rosacea
Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study
To compare the efficacy and safety of 532 nm KTP and 585 nm PDL for treating rosacea.
- Trial name
- NCT05771298
- Testing
- 532nm KTP, 585nm PDL
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Rosacea
A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.
The goal of this clinical trial is to evaluate and demonstrate the therapeutic equivalence and safety of Ivermectin Cream 1%, Soolantra™ Cream 1%, PrRosiver® Cream 1% \& to Placebo for the treatment of moderate to severe facial…
- Trial name
- NCT07795567
- Testing
- Ivermectin Cream 1%, Soolantra™ Cream 1%, PrRosiver® Cream 1%
- Where
- United States
- Volunteers
- 865 people
- Sponsor
- Sun Pharmaceutical Industries, Inc.
Rosacea
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
This study will assess the role of topical Ivermectin 1% cream and its effect on protease and antimicrobial peptide expression and on the skin microbiome (the microorganisms that live on the skin) in rosacea.
- Trial name
- NCT02806414
- Testing
- Ivermectin
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- University of California, San Diego
Acne Rosacea
A Pilot Study on the Use of Seysara for Rosacea
This is a prospective, parallel group, randomized, investigator-blinded pilot study. Approximately 100 subjects will be randomized at a 3:1 ratio to Seysara (sarecycline) at a weight-based dose per label or Centrum Adult…
- Trial name
- NCT04555525
- Testing
- sarecycline, Centrum Adult Multivitamin
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Derm Research, PLLC
Rosacea
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea
This study evaluates a nature-based sensitive skin regimen (NBSSR), as a suitable adjunct topical application to prescription medication when administered daily over the course of four weeks, in moderate to severe rosacea in…
- Trial name
- NCT03392558
- Testing
- Burt's Bees Skin Care Regimen, Control Regimen
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Burt's Bees Inc.
Migraine, Rosacea
Deep Phenotyping of Rosacea and Migraine
This study aims to deep phenotype patients with rosacea and migraine
- Trial name
- NCT03872050
- Testing
- No intervention apart from tests, including interview
- Where
- Denmark
- Volunteers
- 613 people
- Sponsor
- Danish Headache Center
Rosacea, Erythematotelangiectatic, Rosacea Subtype 1 (Erythematotelangiectatic)
Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea.
- Trial name
- NCT07521462
- Testing
- Dermocosmetic tested product, Vascular laser treatment
- Where
- France
- Volunteers
- 50 people
- Sponsor
- ISISPHARMA
Wrinkle, Rosacea
Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment
Evaluate the Cutera excel V™ Laser with Green Genesis and a Micro-Lens Array (MLA) Attachment
- Conditions
- Wrinkle, Rosacea, Scarring
- Trial name
- NCT03424304
- Testing
- Excel V™ Laser With Green Genesis
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Cutera Inc.
Acne Vulgaris, Rosacea
Timolol for the Treatment of Acne and Rosacea
This research is being done to determine the safety and tolerability of timolol in the treatment of acne and rosacea. The investigators will also look for specific biomolecular changes in acne or rosacea skin when it is exposed…
- Trial name
- NCT02774590
- Testing
- Timolol
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Johns Hopkins University
Erythema, Rosacea
Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea
This study will evaluate the safety and efficacy of oxymetazoline hydrochloride (HCl) cream 1.0% (AGN-199201) once daily compared to vehicle for the treatment of persistent moderate to severe facial erythema associated with…
- Trial name
- NCT02132117
- Testing
- Oxymetazoline HCL Cream 1.0%, Vehicle to Oxymetazoline HCL Cream
- Where
- United States
- Volunteers
- 445 people
- Sponsor
- Allergan
Rosacea
Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy
Rosacea is a chronic inflammatory disease of the central facial region, which can also occur in the neck and chest regions. Microbes that play a role in rosacea are Demodex folliculorum and Helicobactor pylori.
- Trial name
- NCT05861310
- Testing
- Metronidazole 1% Cream,Top
- Where
- 2 sites in Indonesia
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Dr.dr.Irma Bernadette, SpKK (K)
Telangiectasia, Rosacea
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser
The goal is to compare a novel yellow laser, based on semiconductor technology, with traditional green laser, in the treatment of cheek telangiectasias.
- Trial name
- NCT03472859
- Testing
- PHOTOLASE, KTP
- Where
- Finland
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Tampere University Hospital
Erythematotelangiectatic Rosacea
Combination Therapy for the Treatment of Rosacea
The purpose of this study is to determine the efficacy of calcium dobesilate in combination with pulsed dye laser for the treatment of rosacea.
- Trial name
- NCT00945373
- Testing
- calcium dobesilate, pulsed dye laser
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Ellen Marmur